Reorganizing Metals: the Use of Chelating Compounds as Potential Therapies for Metal-Related Neurodegenerative Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|11|5|543-552

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.5, 2011-01, pp. : 543-552

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antioxidants as a Potential Therapy Against Age-Related Neurodegenerative Diseases: Amyloid Beta Toxicity and Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 699-704

Bentham Science Publishers

Access to resources Recommend Favorite

Chelating Agents for Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2760-2772

Bentham Science Publishers

Access to resources Recommend Favorite

Antipsychotic drug use in neurodegenerative disease in the elderly: problems and potential from a pharmacological perspective

By Reynolds G.P.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 543-548

Informa Healthcare

Access to resources Recommend Favorite

The Chemistry of Transition Metals in Relation to Their Potential Role in Neurodegenerative Processes

By  

Current Topics in Medicinal Chemistry, Vol. 1, Iss. 6, 2001-12 ,pp. : 541-551

Bentham Science Publishers

Access to resources Recommend Favorite

Metal-Protein Attenuating Compounds (MPACs): An Emerging Approach for the Treatment of Neurodegenerative Disorders

By  

Current Bioactive Compounds, Vol. 4, Iss. 2, 2008-08 ,pp. : 57-67

Bentham Science Publishers

Access to resources Recommend Favorite